These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Australia antigen and blood transfusion. Gocke DJ Vox Sang; 1970; 19(3):327-31. PubMed ID: 4993784 [No Abstract] [Full Text] [Related]
25. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis]. Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897 [No Abstract] [Full Text] [Related]
26. [Enzyme prevention of post-transfusion hepatitis]. Mazhinskaia VP Vestn Khir Im I I Grek; 1970 Dec; 105(12):58-60. PubMed ID: 5514434 [No Abstract] [Full Text] [Related]
27. The hepatitis B saga. Hussey HH JAMA; 1981 Apr; 245(13):1317-8. PubMed ID: 7009897 [No Abstract] [Full Text] [Related]
28. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results. Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039 [TBL] [Abstract][Full Text] [Related]
29. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis. Lenes BA; Tomasulo P; Alter HJ; Holland PV N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702 [No Abstract] [Full Text] [Related]
30. [Study of blood transaminases in blood donors in the prevention of post-transfusional virus hepatitis]. Teofili MT; Tucci G Ann Med Nav (Roma); 1969; 74(2):141-54. PubMed ID: 5405090 [No Abstract] [Full Text] [Related]
31. Hepatitis B antigen: new technics for the reduction of posttransfusion hepatitis. Gitnick GL; Koretz RL Am J Gastroenterol; 1974 May; 61(5):366-70. PubMed ID: 4835933 [No Abstract] [Full Text] [Related]
33. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis. Hollinger FB; Aach RD; Gitnick GL; Roche JK; Melnick JL N Engl J Med; 1973 Aug; 289(8):385-91. PubMed ID: 4719826 [No Abstract] [Full Text] [Related]
34. Failure of Australia antibody to prevent post-transfusion hepatitis. Holland PV; Walsh JH; Morrow AG; Purcell RH Lancet; 1969 Sep; 2(7620):553-5. PubMed ID: 4185530 [No Abstract] [Full Text] [Related]
35. [Decreasing the risk of hepatitis B transfer by regular screening examination of donors for glutamic-oxaloacetic transaminase and for hepatitis BS antigen]. Novak J; Urbánková J Probl Gematol Pereliv Krovi; 1977 Jul; 22(7):56-7. PubMed ID: 882530 [No Abstract] [Full Text] [Related]
37. History of the Discovery of Hepatitis A Virus. Feinstone SM Cold Spring Harb Perspect Med; 2019 May; 9(5):. PubMed ID: 29712682 [TBL] [Abstract][Full Text] [Related]
38. [Prognostic validity of biochemical data and immunofluorescence microscopy in acute hepatitis B (author's transl)]. Ohlen J; Neiss A; Drescher M; Selmair H; Richter J Acta Med Austriaca; 1981; 7(2):56-8. PubMed ID: 7010869 [TBL] [Abstract][Full Text] [Related]
39. [Valve of the estimation of transaminases in blood destined for transfusion]. German A; Galli A; Jeanmaire J Ann Biol Clin (Paris); 1967; 25(5):695-8. PubMed ID: 6059728 [No Abstract] [Full Text] [Related]
40. Transfusion of hepatitis B surface antigen-positive plasma. Prophylaxis with hepatitis B immune globulin. Telischi M; Ziyai M; Steigmann F; Ling CM JAMA; 1980 Nov; 244(20):2312-3. PubMed ID: 7431556 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]